Monoclonal Anti-TNF-α Antibodies for Severe Steroid-Dependent Asthma: A Case Series

BACKGROUND: Refractory asthma represents an important condition, with considerable morbidity and mortality. Tumor necrosis factor α (TNF-α) is a potential target for treatment of severe asthma. However, controlled studies have shown controversial results and the risk-benefit profile of TNF-blocking...

Descripción completa

Detalles Bibliográficos
Autores principales: Taillé, Camille, Poulet, Claire, Marchand-Adam, Sylvain, Borie, Raphaël, Dombret, Marie-Christine, Crestani, Bruno, Aubier, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601337/
https://www.ncbi.nlm.nih.gov/pubmed/23526476
http://dx.doi.org/10.2174/1874306401307010021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601337/
https://www.ncbi.nlm.nih.gov/pubmed/23526476
http://dx.doi.org/10.2174/1874306401307010021

Ejemplares similares